Evaluating Modulation Effects of Temporal Interference Using SEEG

Launched by XUANWU HOSPITAL, BEIJING · Oct 26, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help people with drug-resistant epilepsy, which means their seizures do not respond to standard treatments. The study is examining a technique called temporal interference (TI), which uses special electrical signals to understand how the brain works during seizures. Researchers want to collect data from patients aged 14 to 60 who have already been diagnosed with epilepsy that is hard to treat.

To participate, individuals must have a confirmed diagnosis of drug-resistant epilepsy and be healthy overall, without any serious other health issues. They will also need to have special electrodes placed in their brains for the study. Participants will play an important role in helping researchers learn more about how this new technique might work. If you're considering joining the trial, you should know that the study is currently recruiting participants and everyone involved will be asked to sign a consent form before starting.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of drug-resistant epilepsy;
• • No severe systemic diseases;
• • Implantation of stereotactic electrodes;
• • Agreement to participate in this study and signs the informed consent form.
• Exclusion Criteria:
• • Hematoma at the scalp electrode site or fluid accumulation under the electrode after intracranial electrode placement.